Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene

Journal of Clinical Investigation

Volumn 100, Issue 7, 1997, Pages 1831-1839

  Rossetti, Luciano ^a   Stenbit, Antine E ^a   Chen, Wei ^a   Hu, Meizhu ^a   Barzilai, Nir ^a   Katz, Ellen B ^a   Charron, Maureen J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Gluconeogenesis; Glucose transport; GLUT4; Hepatic glucose production; Insulin resistance

Indexed keywords

GLUCOSE TRANSPORTER; INSULIN;

ADIPOSE TISSUE; ADOLESCENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE DISRUPTION; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; INSULIN RESISTANCE; LIVER METABOLISM; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 0030967868     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119711     Document Type: Article

References (69)

1. Birnbaum, M. 1989. Identification of a novel gene encoding an insulin-responsive glucose transporter protein. Cell. 57:305-315.
2. Charron, M., F.D. Brosius, S. Alper, and H. Lodish. 1989. A glucose transport protein expressed predominately in insulin-responsive tissues. Proc. Natl. Acad. Sci. USA. 86:2535-2539.
3. Mueckler, M. 1994. Facilitative glucose transporters. Eur. J. Biochem. 219:713-725.
4. Kahn, B. 1996. Lilly lecture 1995. Glucose transport: pivotal step in insulin action. Diabetes. 45:1644-1654.
5. Marette, A., E. Burdett, A. Douen, M. Vranic, and A. Klip. 1992. Insulin induces the translocation of GLUT4 from a unique intracellular organelle to transverse tubules in rat skeletal muscle. Diabetes. 41:1562-1569.
6. Wang, W., P. Hansen, B. Marshall, J. Holloszy, and M. Mueckler. 1996. Insulin unmasks a COOH-terminal Glut4 epitope and increases glucose transport across T-tubules in skeletal muscle. J. Cell Biol. 135:415-430.
7. Ren, J., B. Marshall, E. Gulve, J. Gao, D. Johnson, J. Holloszy, and M. Mueckler. 1993. Evidence from transgenic mice that glucose transport is rate-limiting for glycogen deposition and glycolysis in skeletal muscle. J. Biol. Chem. 268:16113-16115.
8. Rossetti, L., and A. Giaccari. 1990. Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats. J. Clin. Invest. 85:1785-1792.
9. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. J. Clin. Invest. 89: 1069-1075.
10. Rossetti, L., and M. Hu. 1993. Skeletal muscle glycogenolysis is more sensitive to insulin than is glucose transport/phosphorylation. Relation to the insulin-induced inhibition of hepatic glucose production. J. Clin. Invest. 92: 2963-2974.
11. Price, T., G. Perseghin, A. Duleba, W. Chen, J. Chase, D. Rothman, R. Shulman, and G. Shulman. 1996. NMR studies of muscle glycogen synthesis in insulin-resistant offspring of parents with non-insulin-dependent diabetes mellitus immediately after glycogen-depleting exercise. Proc. Natl. Acad. Sci. USA. 93:5329-5334.
12. Rothman, D., I. Magnusson, G. Cline, D. Gerard, C. Kahn, R. Shulman, and G. Shulman. 1995. Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA. 92:983-987.
13. Butler, P., E. Kryshak, M. Marsh, and R. Rizza. 1990. Effect of insulin on oxidation of intracellularly and extracellularly derived glucose in patients with NIDDM. Evidence for primary defect in glucose transport and/or phosphorylation but not oxidation. Diabetes. 39:1373-1380.
14. Bonadonna, R., S. Del Prato, M. Saccomani, E. Bonora, G. Gulli, E. Ferrannini, D. Bier, C. Cobelli, and R. DeFronzo. 1993. Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. J. Clin. Invest. 92:486-494.
15. Bonadonna, R., S. Del Prato, E. Bonora, M. Saccomani, G. Gulli, A. Natali, S. Frascerra, N. Pecori, E. Ferrannini, D. Bier, et al. 1996. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes. 45:915-925.
16. Eriksson, J., L. Koranyi, R. Bourey, C. Schalin-Jantti, E. Widen, M. Mueckler, A.M. Permutt, and L.C. Groop. 1994. Insulin resistance in Type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle. Diabetologia. 35:143-147.
17. Kusari, J., U. Verma, J. Buse, R. Henry, and J. Olefsky. 1991. Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT-4) in patients with common-type non-insulin-dependent diabetes mellitus. J. Clin. Invest. 88:1323-1330.
18. Andersen, P., S. Lund, H. Vestergaard, S. Junker, B. Kahn, and O. Pedersen. 1993. Expression of the major insulin regulatable glucose transporter (GLUT4) in skeletal muscle of non-insulin-dependent diabetic patients and healthy subjects before and after insulin infusion. J. Clin. Endocrinol. Metab. 77:27-32.
19. Koranyi, L., R. Bourey, H. Vuorinen-Markkola, V. Koivisto, M. Mueckler, M. Permutt, and H. Yki-Jarvinen. 1991. Level of skeletal muscle glucose transporter protein correlates with insulin-stimulated whole body glucose disposal in man. Diabetologia. 34:763-765.
20. Schalin-Jantti, C., H. Yki-Jarvinen, L. Koranyi, R. Bourey, J. Lindstrom, P. Nikula-Ijas, A. Franssila-Kallunki, and L. Groop. 1994. Effect of insulin on GLUT-4 mRNA and protein concentrations in skeletal muscle of patients with NIDDM and their first-degree relatives. Diabetologia. 37:401-407.
21. Pedersen, O., J. Bak, P. Andersen, S. Lund, D. Moller, J. Flier, and B. Kahn. 1990. Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients wilh obesity or NIDDM. Diabetes. 39:865-870.
22. Hollenbeck, C., and G. Reaven. 1987. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J. Clin. Endocrinol. Metab. 64:1169-1173.
23. Thorhurn, A., B. Gumbiner, F. Bulacan, G. Brechtel, and R. Henry. 1991. Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin-dependent diabetes mellitus. J. Clin. Invest. 87:484-495.
24. Thorhurn, A., B. Gumhiner, F. Bulacan, P. Wallace, and R. Henry. 1990. Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. J. Clin. Invest. 85:522-529.
25. Gulli, G., E. Ferrannini, M. Stern, S. Haffner, and R. DeFronzo. 1992. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes. 41:1575-1586.
26. Groop, L., R. Bonadonna, S. DelPrato, K. Ratheiser, K. Zyck, E. Ferrannini, and R. DeFronzo. 1989. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J. Clin. Invest. 84:205-213.
27. Butler, P., E. Kryshak, W. Schwenk, M. Haymond, and R. Rizza. 1990. Hepatic and extrahepatic responses to insulin in NIDDM and nondiabetic humans. Assessment in absence of artifact introduced by tritiated nonglucose contaminants. Diabetes. 39:217-225.
28. Del Prato, S., R. Bonadonna, E. Bonora, G. Gulli, A. Solini, M. Shank, and R. DeFronzo. 1993. Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus. J. Clin. Invest. 91:484-494.
29. Vaag, A., F. Alford, F. Henriksen, M. Christopher, and H. Beck-Nielsen. 1995. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM. Diabetologia. 38: 326-336.
30. Vaag, A., J. Henriksen, and H. Beck-Nielsen. 1992. Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest. 89:782-788.
31. 13C nuclear magnetic resonance spectroscopy. N. Engl. J. Med. 322:223-228.
32. Giacca, A., S. Fisher, Z. Shi, R. Gupta, H. Lickley, and M. Vranic. 1992. Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs. J. Clin. Invest. 90:1769-1777.
33. Bradley, D., R. Poulin, and R. Bergman. 1993. Dynamics of hepatic and peripheral insulin effects suggest common rate-limiting step in vivo. Diabetes. 42:296-306.
34. Lewis, G., B. Zinman, Y. Groenewoud, M. Vranic, and A. Giacca. 1996. Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes. 45:454-462.
35. Ren, J., B. Marshall, M. Mueckler, M. McCaleb, J. Amatruda, and G. Shulman. 1995. Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice. J. Clin. Invest. 95:429-432.
36. Rossetti, L., N. Barzilai, W. Chen, T. Harris, D. Yang, and C.E. Rogler. 1996. Hepatic overexpression of insulin-like growth factor-II in adulthood increases basal and insulin-stimulated glucose disposal in conscious mice. J. Biol. Chem. 271:203-208.
37. Turk, D., A. Alzaid, S. Dinneen, K.S. Nair, and R. Rizza. 1995. The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues. J. Clin. Invest. 95:755-762.
38. Vaag, A., J. Henriksen, S. Madsbad, N. Holm, and H. Beck-Nielsen. 1995. Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J. Clin. Invest. 95:690-698.
39. Ferrannini, E., G. Buzzigoli, R. Bonadonna, M. Giorico, M. Oleggini, L. Graziadei, R. Pedrinelli, L. Brandi, and S. Bevilacqua. 1987. Insulin resistance in essential hypertension. N. Engl. J. Med. 317:350-357.
40. Bianchi, S., R. Bigazzi, A. Quinones-Galvan, E. Muscelli, G. Baldari, N. Pecori, D. Ciociaro, E. Ferrannini, and A. Natali. 1995. Insulin resistance in microalbuminuric hypertension. Sites and mechanisms. Hypertension (Dallas). 26: 789-795.
41. Katz, E., A. Stenbit, K. Hatton, R. DePinho, and M. Charron. 1995. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature (Lond.). 377:151-155.
42. Massillon, D., W. Chen, M. Hawkins, R. Liu, N. Barzilai, and L. Rossetti. 1995. Quantitation of hepatic glucose fluxes and pathways of hepatic glycogen synthesis in conscious mice. Am. J. Physiol. 269:E1037-E1043.
43. Bali, D., A. Svetlanov, H.W. Lee, D. Fusco-DeMane, M. Leiser, B. Li, N. Barzilai, M. Surana, H. Hou, N. Fleischer, et al. 1995. Animal model for maturity-onset diabetes of the young generated by disruption of the mouse glucokinase gene. J. Biol. Chem. 270:21464-21467.
44. Rossetti, L., D. Smith, G.I. Shulman, D. Papachristou, and R.A. DeFronzo. 1987. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J. Clin. Invest. 79:1510-1515.
45. Rossetti, L., A. Giaccari, N. Barzilai, K. Howard, O. Sebel, and M. Hu. 1993. Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes. J. Clin. Invest. 92:1126-1134.
46. Kraegen, E., D. James, A. Jenkins, and P. Chisolm. 1985. Dose-response curves for in vivo insulin sensitivity for individual tissues in rats. Am. J. Physiol. 248:E353-E362.
47. Rossetti, L., and M. Laughlin. 1989. Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle. J. Clin. Invest. 84:892-899.
48. Giaccari, A., and L. Rossetti. 1989. Isocratic high-performance liquid chromatographic determination of the concentration and specific radioactivity of phosphoenolpyruvate and uridine diphosphate glucose in tissue extracts. J. Chromatogr. 497:69-78.
49. Giaccari, A., and L. Rossetti. 1992. Predominant role of gluconeogenesis in the hepatic glycogen repletion of diabetic rats. J. Clin. Invest. 89:36-45.
50. Tsao, T., R. Burcelin, E. Katz, L. Huang, and M. Charron. 1996. Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle. Diabetes. 45:28-36.
51. Stenbit, A.E., R. Burcelin, E. Katz, T. Tsao, N. Gautier, M. Charron, and Y. Le Marchand-Brustel. 1996. Diverse effects of Glut 4 ablation on glucose uptake and glycogen synthesis in red and white skeletal muscle. J. Clin. Invest. 98:629-634.
52. Marshall, B., J. Ren, D. Johnson, E. Gibbs, J. Lillquist, W. Soeller, J. Holloszy, and M. Mueckler. 1993. Germline manipulation of glucose homeostasis via alteration of glucose transporter levels in skeletal muscle. J. Biol. Chem. 268:18442-18445.
53. Kahn, B., L. Rossetti, H. Lodish, and M. Charron. 1991. Decreased in vivo glucose uptake but normal expression of GLUT1 and GLUT4 in skeletal muscle of diabetic rats. J. Clin. Invest. 87:2197-2206.
54. Kahn, B., G. Shulman, R. DeFronzo, S. Cushman, and L. Rossetti. 1991. Normalization of blood glucose in diabetic rats with phlorizin treatment reverses insulin-resistant glucose transport in adipose cells without restoring glucose transporter gene expression. J. Clin. Invest. 87:561-570.
55. Dimitrakoudis, D., T. Ramlal, S. Rastogi, M. Vranic, and A. Klip. 1992. Glycaemia regulates the glucose transporter number in the plasma membrane of rat skeletal muscle. Biochem. J. 284:341-348.
56. Roden, M., T. Price, G. Perseghin, K. Petersen, D. Rothman, G. Cline, and G. Shulman. 1996. Mechanism of free fatty acid-induced insulin resistance in humans. J. Clin. Invest. 97:2859-2865.
57. Zierath, J., K. Houseknecht, L. Gnudi, and B. Kahn. 1997. High-fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin-signaling defect. Diabetes. 46:215-223.
58. Gulve, E., J. Ren, B. Marshall, J. Gao, P. Hansen, J. Holloszy, and M. Mueckler. 1994. Glucose transport activity in skeletal muscles from transgenic mice overexpressing GLUT1. Increased basal transport is associated with a defective response to diverse stimuli that activate GLUT4. J. Biol. Chem. 269: 17765-17767.
59. Hansen, P., E. Gulve, B. Marshall, J. Gao, J. Pessin, J. Holloszy, and M. Mueckler. 1995. Skeletal muscle glucose transport and metabolism are enhanced in transgenic mice overexpressing the Glut4 glucose transporter. J. Biol. Chem. 270:1679-1684.
60. Leturque, A., M. Loizeau, S. Vaulont, M. Salminen, and J. Girard. 1996. Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle. Diabetes. 45:23-27.
61. Liu, M., E. Gibbs, S. McCoid, A. Milici, H. Stukenbrok, R. McPherson, J. Treadway, and J. Pessin. 1993. Transgenic mice expressing the human GLUT4/muscle-fat facultative glucose transporter protein exhibit efficient glycemic control. J. Biol. Chem. 268:22231-22234.
62. Treadway, J., D. Hargrove, N. Nardone, R. McPherson, J. Russo, A. Milici, H. Stukenbrok, E. Gibbs, R. Stevenson, and J. Pessin. 1994. Enhanced peripheral glucose utilization in transgenic mice expressing the human GLUT4 gene. J. Biol. Chem. 269:29956-29961.
63. Shepherd, P., L. Gnudi, E. Tozzo, H. Yang, F. Leach, and B. Kahn. 1993. Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J. Biol. Chem. 268: 22243-22246.
64. Gibbs, E., J. Slock, S. McCoid, H. Stukenbrok, J. Pessin, R. Stevenson, A. Milici, and J. McNeish. 1995. Glycemic improvement in diabetic db/db mice by overexpression of the human insulin-regulatable glucose transporter (GLUT4). J. Clin. Invest. 95:1512-1518.
65. Vaag, A., P. Damsbo, O. Hother-Nielsen, and H. Beck-Nielsen. 1992. Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 35: 80-88.
66. Rebrin, K., G. Steil, S. Mittelman, and R. Bergman. 1996. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J. Clin. Invest. 98:741-749.
67. Ader, M., and R. Bergman. 1990. Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am. J. Physiol. 258:E1020-E1032.
68. Rebrin, K., G. Steil, L. Getty, and R. Bergman. 1995. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes. 44:1038-1045.
69. Boden, G., X. Chen, J. Ruiz, J. White, and L. Rossetti. 1994. Mechanisms of fatty acid-induced inhibition of glucose uptake. J. Clin. Invest. 93:2438-2446.